Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis ; volume:21 ; number:1 ; day:9 ; month:5 ; year:2019 ; pages:1-11 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (9.5.2019), 1-11, 12.2019
- Creator
-
Alivernini, Stefano
Bruno, Dario
Tolusso, Barbara
Bui, Laura
Petricca, Luca
Gigante, Maria Rita
Birra, Domenico
Fedele, Anna Laura
Peluso, Giusy
Federico, Francesco
Ferraccioli, Gianfranco
Gremese, Elisa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1898-7
- URN
-
urn:nbn:de:101:1-2019090122465436503528
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alivernini, Stefano
- Bruno, Dario
- Tolusso, Barbara
- Bui, Laura
- Petricca, Luca
- Gigante, Maria Rita
- Birra, Domenico
- Fedele, Anna Laura
- Peluso, Giusy
- Federico, Francesco
- Ferraccioli, Gianfranco
- Gremese, Elisa
- SpringerLink (Online service)
Other Objects (12)
Synovial fluid proteome in rheumatoid arthritis
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
Rheumatoid arthritis
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
Hyporesponsive synovial fluid T-cells in rheumatoid arthritis
Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
Hyporesponsive synovial fluid T-cells in rheumatoid arthritis
Molecular mechanisms of synovial fibroblast activation in rheumatoid arthritis
Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
Targeting activated synovial fibroblasts in rheumatoid arthritis by peficitinib
Rheumatoid arthritis, [1]
Synovial fluid proteome in rheumatoid arthritis
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
Rheumatoid arthritis
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
Hyporesponsive synovial fluid T-cells in rheumatoid arthritis
Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
Hyporesponsive synovial fluid T-cells in rheumatoid arthritis
Molecular mechanisms of synovial fibroblast activation in rheumatoid arthritis
Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
Targeting activated synovial fibroblasts in rheumatoid arthritis by peficitinib
Rheumatoid arthritis, [1]
Synovial fluid proteome in rheumatoid arthritis
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
Rheumatoid arthritis
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
Hyporesponsive synovial fluid T-cells in rheumatoid arthritis
Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
Hyporesponsive synovial fluid T-cells in rheumatoid arthritis
Molecular mechanisms of synovial fibroblast activation in rheumatoid arthritis
Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
Targeting activated synovial fibroblasts in rheumatoid arthritis by peficitinib